212 related articles for article (PubMed ID: 30954625)
1. A computational study of the dual effect of intermittent and continuous administration of parathyroid hormone on bone remodeling.
Zhao Y; Zhang G
Acta Biomater; 2019 Jul; 93():200-209. PubMed ID: 30954625
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone temporal effects on bone formation and resorption.
Kroll MH
Bull Math Biol; 2000 Jan; 62(1):163-88. PubMed ID: 10824426
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways.
Cupp ME; Nayak SK; Adem AS; Thomsen WJ
J Pharmacol Exp Ther; 2013 Jun; 345(3):404-18. PubMed ID: 23516330
[TBL] [Abstract][Full Text] [Related]
4. Physiological and Pharmacological Roles of PTH and PTHrP in Bone Using Their Shared Receptor, PTH1R.
Martin TJ; Sims NA; Seeman E
Endocr Rev; 2021 Jul; 42(4):383-406. PubMed ID: 33564837
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 as a target for the proliferative effects of PTH and PTHrP in early osteoblastic cells.
Datta NS; Pettway GJ; Chen C; Koh AJ; McCauley LK
J Bone Miner Res; 2007 Jul; 22(7):951-64. PubMed ID: 17501623
[TBL] [Abstract][Full Text] [Related]
6. Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies.
Esbrit P; Alcaraz MJ
Biochem Pharmacol; 2013 May; 85(10):1417-23. PubMed ID: 23500550
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone-dependent signaling pathways regulating genes in bone cells.
Swarthout JT; D'Alonzo RC; Selvamurugan N; Partridge NC
Gene; 2002 Jan; 282(1-2):1-17. PubMed ID: 11814673
[TBL] [Abstract][Full Text] [Related]
8. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation.
Zhu Q; Zhou X; Zhu M; Wang Q; Goltzman D; Karaplis A; Miao D
J Bone Miner Res; 2013 Sep; 28(9):1898-911. PubMed ID: 23716486
[TBL] [Abstract][Full Text] [Related]
9. Distinct roles for mitogen-activated protein kinase phosphatase-1 (MKP-1) and ERK-MAPK in PTH1R signaling during osteoblast proliferation and differentiation.
Datta NS; Kolailat R; Fite A; Pettway G; Abou-Samra AB
Cell Signal; 2010 Mar; 22(3):457-66. PubMed ID: 19892016
[TBL] [Abstract][Full Text] [Related]
10. Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells.
van der Horst G; Farih-Sips H; Löwik CW; Karperien M
J Bone Miner Res; 2005 Dec; 20(12):2233-44. PubMed ID: 16294276
[TBL] [Abstract][Full Text] [Related]
11. Continuous elevation of PTH increases the number of osteoblasts via both osteoclast-dependent and -independent mechanisms.
Jilka RL; O'Brien CA; Bartell SM; Weinstein RS; Manolagas SC
J Bone Miner Res; 2010 Nov; 25(11):2427-37. PubMed ID: 20533302
[TBL] [Abstract][Full Text] [Related]
12. Involvement of dual signal transduction systems in the stimulation of osteoclast-like cell formation by parathyroid hormone and parathyroid hormone-related peptide.
Kaji H; Sugimoto T; Kanatani M; Fukase M; Chihara K
Biochem Biophys Res Commun; 1993 Jul; 194(1):157-62. PubMed ID: 8392835
[TBL] [Abstract][Full Text] [Related]
13. A 7-day continuous infusion of PTH or PTHrP suppresses bone formation and uncouples bone turnover.
Horwitz MJ; Tedesco MB; Sereika SM; Prebehala L; Gundberg CM; Hollis BW; Bisello A; Garcia-Ocaña A; Carneiro RM; Stewart AF
J Bone Miner Res; 2011 Sep; 26(9):2287-97. PubMed ID: 21544866
[TBL] [Abstract][Full Text] [Related]
14. Second messenger signaling of c-fos gene induction by parathyroid hormone (PTH) and PTH-related peptide in osteoblastic osteosarcoma cells: its role in osteoblast proliferation and osteoclast-like cell formation.
Kano J; Sugimoto T; Kanatani M; Kuroki Y; Tsukamoto T; Fukase M; Chihara K
J Cell Physiol; 1994 Nov; 161(2):358-66. PubMed ID: 7962120
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Bone Remodeling by Parathyroid Hormone.
Wein MN; Kronenberg HM
Cold Spring Harb Perspect Med; 2018 Aug; 8(8):. PubMed ID: 29358318
[TBL] [Abstract][Full Text] [Related]
16. PTH/PTHrP in controlled release hydrogel enhances orthodontic tooth movement by regulating periodontal bone remodaling.
Lu W; Li X; Yang Y; Yi J; Xie L; Zhao Z; Li Y
J Periodontal Res; 2021 Oct; 56(5):885-896. PubMed ID: 33856055
[TBL] [Abstract][Full Text] [Related]
17. Mathematical model of paracrine interactions between osteoclasts and osteoblasts predicts anabolic action of parathyroid hormone on bone.
Komarova SV
Endocrinology; 2005 Aug; 146(8):3589-95. PubMed ID: 15860557
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone: anabolic and catabolic actions on the skeleton.
Silva BC; Bilezikian JP
Curr Opin Pharmacol; 2015 Jun; 22():41-50. PubMed ID: 25854704
[TBL] [Abstract][Full Text] [Related]
19. The chemokine Cxcl1 is a novel target gene of parathyroid hormone (PTH)/PTH-related protein in committed osteoblasts.
Onan D; Allan EH; Quinn JM; Gooi JH; Pompolo S; Sims NA; Gillespie MT; Martin TJ
Endocrinology; 2009 May; 150(5):2244-53. PubMed ID: 19147675
[TBL] [Abstract][Full Text] [Related]
20. EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts.
Allan EH; Häusler KD; Wei T; Gooi JH; Quinn JM; Crimeen-Irwin B; Pompolo S; Sims NA; Gillespie MT; Onyia JE; Martin TJ
J Bone Miner Res; 2008 Aug; 23(8):1170-81. PubMed ID: 18627264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
